AC regimen

(Redirected from CA regimen)
Jump to navigation Jump to search

WikiDoc Resources for AC regimen


Most recent articles on AC regimen

Most cited articles on AC regimen

Review articles on AC regimen

Articles on AC regimen in N Eng J Med, Lancet, BMJ


Powerpoint slides on AC regimen

Images of AC regimen

Photos of AC regimen

Podcasts & MP3s on AC regimen

Videos on AC regimen

Evidence Based Medicine

Cochrane Collaboration on AC regimen

Bandolier on AC regimen

TRIP on AC regimen

Clinical Trials

Ongoing Trials on AC regimen at Clinical

Trial results on AC regimen

Clinical Trials on AC regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on AC regimen

NICE Guidance on AC regimen


FDA on AC regimen

CDC on AC regimen


Books on AC regimen


AC regimen in the news

Be alerted to news on AC regimen

News trends on AC regimen


Blogs on AC regimen


Definitions of AC regimen

Patient Resources / Community

Patient resources on AC regimen

Discussion groups on AC regimen

Patient Handouts on AC regimen

Directions to Hospitals Treating AC regimen

Risk calculators and risk factors for AC regimen

Healthcare Provider Resources

Symptoms of AC regimen

Causes & Risk Factors for AC regimen

Diagnostic studies for AC regimen

Treatment of AC regimen

Continuing Medical Education (CME)

CME Programs on AC regimen


AC regimen en Espanol

AC regimen en Francais


AC regimen in the Marketplace

Patents on AC regimen

Experimental / Informatics

List of terms related to AC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: AC; AC Regimen; Adriamycin-Cytoxan Regimen; CA Regimen.


AC regimen refers to a regimen consisting of cyclophosphamide and doxorubicin used in the adjuvant setting for the treatment of breast cancer; also used for the treatment of recurrent and metastatic breast cancer.[1][2]


ADoxorubicin (Adriamycin)




  1. "NCI Thesaurus".
  2. "R-CHOP - National Cancer Institute".
  3. Perez EA, Geeraerts L, Suman VJ, Adjei AA, Baron AT, Hatfield AK; et al. (2002). "A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer". Ann Oncol. 13 (8): 1225–35. PMID 12181246.